Impact of AUC/MIC ratios on the pharmacodynamics of the des-F(6) quinolone garenoxacin (BMS-284756) is similar to other fluoroquinolones

被引：15

作者：

Lister, PD ^{[1
]}

机构：

[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Antiinfect & Biotechnol, Omaha, NE 68178 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 01期

关键词：

D O I：

10.1093/jac/dkg017

中图分类号：

R51 [传染病];

学科分类号：

100401 [流行病与卫生统计学];

摘要：

引用

页码：199 / 201

页数：3

共 6 条

[1]

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections [J].

Ambrose, PG ;

Grasela, DM ;

Grasela, TH ;

Passarell, J ;

Mayer, HB ;

Pierce, PF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2793-2797

[2]

PHARMACODYNAMICS OF A FLUOROQUINOLONE ANTIMICROBIAL AGENT IN A NEUTROPENIC RAT MODEL OF PSEUDOMONAS SEPSIS [J].

DRUSANO, GL ;

JOHNSON, DE ;

ROSEN, M ;

STANDIFORD, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :483-490

[3]

Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 [J].

Fung-Tomc, JC ;

Minassian, B ;

Kolek, B ;

Huczko, E ;

Aleksunes, L ;

Stickle, T ;

Washo, T ;

Gradelski, E ;

Valera, L ;

Bonner, DP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3351-3356

[4]

Pharmaco dynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model:: Impact of area under the curve/MIC ratios on eradication [J].

Lister, PD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :69-74

[5]

Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae [J].

Lister, PD ;

Sanders, CC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (06) :811-818

[6]

Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays [J].

Wu, P ;

Lawrence, LE ;

Denbleyker, KL ;

Barrett, JF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3660-3662

← 1 →